Literature DB >> 27776721

Primary Aldosteronism: Diagnosis and Management.

Geeta Gyamlani1, Carol M Headley2, Adnan Naseer3, Ganpat S Valaulikar4, Stephen A Geraci5.   

Abstract

Primary aldosteronism (PA) is an important and commonly unrecognized cause of secondary hypertension. Idiopathic hyperaldosteronism and aldosterone-producing adenomas account for more than 95% of PA and are characterized, respectively, by bilateral or unilateral involvement of the adrenal glands. When there is suspicion for the presence of PA, a plasma aldosterone to renin ratio should be obtained initially. Localization to determine adrenal gland involvement is done by imaging, with computerized tomography or magnetic resonance imaging. After imaging, adrenal vein sampling is done to establish treatment options. Patients with unilateral disease, who are good surgical candidates, are most appropriately managed with adrenalectomy. A biochemical cure is almost certain following adrenalectomy; however, only 30-50% of patients would show adequate blood pressure improvement. Patients with bilateral adrenal disease and those believed not to be surgical candidates are managed with mineralocorticoid antagonists. Published by Elsevier Inc.

Entities:  

Keywords:  Diagnosis; Hypertension; Outcome; Primary aldosteronism; Treatment

Mesh:

Year:  2016        PMID: 27776721     DOI: 10.1016/j.amjms.2016.06.015

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Aldosterone Suppresses Endothelial Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen Species Pathway.

Authors:  Shih-Yuan Peng; Cheng-Hsuan Tsai; Xue-Ming Wu; Hsin-Hsiu Huang; Zheng-Wei Chen; Bo-Ching Lee; Yi-Yao Chang; Chien-Ting Pan; Vin-Cent Wu; Chia-Hung Chou; Chi-Sheng Hung; Che-Wei Liao; Yen-Hung Lin
Journal:  Biomedicines       Date:  2022-05-12

Review 2.  Primary Aldosteronism and Cerebrovascular Diseases.

Authors:  Zheng Wei Chen; Chi Sheng Hung; Vin Cent Wu; Yen Hung Lin
Journal:  Endocrinol Metab (Seoul)       Date:  2018-12

3.  Liddle syndrome misdiagnosed as primary aldosteronism resulting from a novel frameshift mutation of SCNN1B.

Authors:  Peng Fan; Chao-Xia Lu; Di Zhang; Kun-Qi Yang; Pei-Pei Lu; Ying Zhang; Xu Meng; Su-Fang Hao; Fang Luo; Ya-Xin Liu; Hui-Min Zhang; Lei Song; Jun Cai; Xue Zhang; Xian-Liang Zhou
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

Review 4.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

5.  A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling.

Authors:  Ryo Nakamaru; Koichi Yamamoto; Satoko Nozato; Kazuhiro Hongyo; Motonori Nagasawa; Hideharu Hagiya; Futoshi Nakagami; Hiroshi Akasaka; Hitomi Kurinami; Yoichi Takami; Yasushi Takeya; Ken Sugimoto; Takeshi Ujike; Motohide Uemura; Norio Nonomura; Hiromi Rakugi
Journal:  Clin Case Rep       Date:  2019-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.